New malaria pill takes first step: is it safe for humans?
NCT ID NCT06854042
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 36 times
Summary
This early-stage study tests a single dose of an experimental oral drug called E1018 in 32 healthy adults aged 18 to 55. The main goal is to check if the drug is safe and how the body absorbs and removes it. No treatment or prevention benefit is expected for participants. The results will guide future studies in people with malaria.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
PPD Development, LP
RECRUITINGAustin, Texas, 78744, United States
Conditions
Explore the condition pages connected to this study.